A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography

被引:134
作者
Tilanus-Linthorst, M
Verhoog, L
Obdeijn, IM
Bartels, K
Menke-Pluymers, M
Eggermont, A
Klijn, J
Meijers-Heijboer, H
van der Kwast, T
Brekelmans, C
机构
[1] Erasmus Univ, Med Ctr, Dept Surg, NL-3008 AE Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Pathol, NL-3008 AE Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Radiol, NL-3008 AE Rotterdam, Netherlands
[4] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3008 AE Rotterdam, Netherlands
[5] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3008 AE Rotterdam, Netherlands
关键词
breast cancer; BRCA1; BRCA2; histology; mammography; false-negative; MRI; young patients; surveillance;
D O I
10.1002/ijc.10666
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Female BRCA1/2 mutation carriers develop in up to 50% breast cancer (BC) before age 50 years. We investigated whether the specific histologic features of BRCA1/2-associated breast cancer influence imaging. We correlated the mammographic results with the histology of 34 BC in BRCA1/2 mutation carriers and 34 sporadic cancers in patients, matched for age and year of diagnosis. Mammography was significantly more frequently false-negative in carriers than controls (62% vs. 29% p = 0.01), despite comparable tumor size (mean circle divide 1.51 vs. 1.75) and breast density (high 41% vs. 53%). The image in carriers was significantly less as spiculated mass (6 vs. 18p = 0.01). Cancers of BRCA1/2 mutation carriers had frequently higher mitotic counts (p < 0.0001) and prominent pushing margins around the tumor (p = 0.08) (p = 0.05 for 32 BRCA1). We also observed that prominent "pushing margins" correlated significantly with a false-negative mammography (p = 0.005) and with a mammographic image of a smooth, not a spiculated, mass (p = 0.01). False-negative mammography correlated independently with: BRCA1/2 mutation (p = 0.02), prominent pushing margins (p = 0.03) and high breast density (p = 0.01). MRI was carried out in 12 carriers, had 100% sensitivity and detected 5 cancers, still occult at physical examination and mammography. A BRCA1/2 mutation and high breast density at mammography contribute independently to false-negative mammography results. In mutation carriers any mammographic mass must be regarded with suspicion. Pushing margins of the tumor partly explain these results. For early BC detection in mutation carriers additional methods like MR1 may be needed. This may not be necessary in other young women with breast symptoms. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 24 条
[1]  
Armes JE, 1998, CANCER-AM CANCER SOC, V83, P2335, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO
[2]  
2-N
[3]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[4]  
Eisinger F, 1998, CANCER RES, V58, P1588
[5]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[6]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[7]   Are breast cancers in young women qualitatively distinct? [J].
Henderson, IC ;
Patek, AJ .
LANCET, 1997, 349 (9064) :1488-1489
[8]   International investigation of breast MRI:: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions [J].
Heywang-Körunner, SH ;
Bick, U ;
Bradley, WG ;
Boné, B ;
Casselman, J ;
Coulthard, A ;
Fischer, U ;
Müller-Schimpfle, M ;
Oellinger, H ;
Patt, R ;
Teubner, J ;
Friedrich, M ;
Newstead, G ;
Holland, R ;
Schauer, A ;
Sickles, EA ;
Tabar, L ;
Waisman, J ;
Wernecke, KD .
EUROPEAN RADIOLOGY, 2001, 11 (04) :531-546
[9]  
HOLLAND R, 1983, CANCER, V52, P1810, DOI 10.1002/1097-0142(19831115)52:10<1810::AID-CNCR2820521009>3.0.CO
[10]  
2-F